Absorption and disposition of MeIQx in man: lessons for human dosimetry.
Boobis
A R
AR
Department of Clinical Pharmacology, Royal Postgraduate Medical School, London, United Kingdom.
Gooderham
N J
NJ
Murray
B P
BP
Murray
S
S
Lynch
A
A
Sesardic
D
D
Davies
D S
DS
D000042:Absorption; D000818:Animals; D001711:Biotransformation; D002273:Carcinogens / Q000008:administration & dosage / Q000378:metabolism / Q000493:pharmacokinetics; D004305:Dose-Response Relationship, Drug; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D009153:Mutagens / Q000008:administration & dosage / Q000378:metabolism / Q000493:pharmacokinetics*; D011810:Quinoxalines / Q000008:administration & dosage / Q000378:metabolism / Q000493:pharmacokinetics*
D002273:Carcinogens; D006454:Hemoglobins; D009153:Mutagens; D011810:Quinoxalines; C036990:2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline